Cross-Neutralizing and Protective Human Antibody Specificities to Poxvirus Infections

Monkeypox (MPXV) and cowpox (CPXV) are emerging agents that cause severe human infections on an intermittent basis, and variola virus (VARV) has potential for use as an agent of bioterror. Vaccinia immune globulin (VIG) has been used therapeutically to treat severe orthopoxvirus infections but is in...

Descripción completa

Detalles Bibliográficos
Autores principales: Gilchuk, Iuliia, Gilchuk, Pavlo, Sapparapu, Gopal, Lampley, Rebecca, Singh, Vidisha, Kose, Nurgun, Blum, David L., Hughes, Laura J., Satheshkumar, Panayampalli S., Townsend, Michael B., Kondas, Ashley V., Reed, Zachary, Weiner, Zachary, Olson, Victoria A., Hammarlund, Erika, Raue, Hans-Peter, Slifka, Mark K., Slaughter, James C., Graham, Barney S., Edwards, Kathryn M., Eisenberg, Roselyn J., Cohen, Gary H., Joyce, Sebastian, Crowe, James E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Inc. 2016
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5093772/
https://www.ncbi.nlm.nih.gov/pubmed/27768891
http://dx.doi.org/10.1016/j.cell.2016.09.049

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5093772/
https://www.ncbi.nlm.nih.gov/pubmed/27768891
http://dx.doi.org/10.1016/j.cell.2016.09.049

Ejemplares similares